From blood to the brain: Can systemically transplanted mesenchymal stem cells cross the blood-brain barrier?

Stem Cells International

Volumn , Issue , 2013, Pages

  Liu, Linan ^a   Eckert, Mark A ^a   Riazifar, Hamidreza ^a   Kang, Dong Ku ^a   Agalliu, Dritan ^a   Zhao, Weian ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; BETA INTERFERON; CLAUDIN; CLAUDIN 12; CLAUDIN 5; COUMARIN; CXCL16 CHEMOKINE; CXCL9 CHEMOKINE; JUNCTIONAL ADHESION MOLECULE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; OCCLUDIN; POLYLACTIC ACID; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BRAIN TUMOR; CELL FATE; CELL HOMING; CELL INTERACTION; CELL MIGRATION; CELL TRANSPORT; GENETIC ENGINEERING; GLIOBLASTOMA; HUMAN; LEUKOCYTE MIGRATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR MECHANICS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TIGHT JUNCTION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84884240313     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2013/435093     Document Type: Review

References (65)

1. Trounson A., New perspectives in human stem cell therapeutic research. BMC Medicine 2009 7 article 29 2-s2.0-67650150113 10.1186/1741-7015-7-29
2. Ankrum J., Karp J. M., Mesenchymal stem cell therapy: two steps forward, one step back. Trends in Molecular Medicine 2010 16 5 203 209 2-s2.0-77952319188 10.1016/j.molmed.2010.02.005
3. Karp J. M., Teo G. S. L., Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009 4 3 206 216 2-s2.0-60849136593 10.1016/j.stem.2009.02.001
4. Caplan A. I., Correa D., The MSC: an injury drugstore. Cell Stem Cell 2011 9 1 11 15 2-s2.0-79959951133 10.1016/j.stem.2011.06.008
5. Cyranoski D., Canada approves stem cell product. Nature Biotechnology 2012 30 7 571 10.1038/nbt0712-571b
6. Brooke G., Cook M., Blair C., Han R., Heazlewood C., Jones B., Kambouris M., Kollar K., McTaggart S., Pelekanos R., Rice A., Rossetti T., Atkinson K., Therapeutic applications of mesenchymal stromal cells. Seminars in Cell and Developmental Biology 2007 18 6 846 858 2-s2.0-36248959280 10.1016/j.semcdb. 2007.09.012
7. Dharmasaroja P., Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke. Journal of Clinical Neuroscience 2009 16 1 12 20 2-s2.0-57049089034 10.1016/j.jocn.2008.05.006
8. Kim S. M., Woo J. S., Jeong C. H., Ryu C. H., Lim J. Y., Jeun S. S., Effective combination therapy for malignant glioma with TRAIL-secreting mesenchymal stem cells and lipoxygenase inhibitor MK886. Cancer Research 2012 72 18 4807 4817 10.1158/0008-5472.CAN-12-0123
9. Studeny M., Marini F. C., Dembinski J. L., Zompetta C., Cabreira-Hansen M., Bekele B. N., Champlin R. E., Andreef M., Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. Journal of the National Cancer Institute 2004 96 21 1593 1603 2-s2.0-7944220831 10.1093/jnci/djh299
10. Ahmed A. U., Tyler M. A., Thaci B., Alexiades N. G., Han Y., Ulasov I. V., Lesniak M. S., A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma. Molecular Pharmaceutics 2011 8 5 1559 1572 2-s2.0-80053480063 10.1021/mp200161f
11. Abbott N. J., Patabendige A. A. K., Dolman D. E. M., Yusof S. R., Begley D. J., Structure and function of the blood-brain barrier. Neurobiology of Disease 2010 37 1 13 25 2-s2.0-70449529433 10.1016/j.nbd.2009.07.030
12. Zlokovic B. V., The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008 57 2 178 201 2-s2.0-38149090292 10.1016/j.neuron.2008.01.003
13. Anderson J. M., van Itallie C. M., Physiology and function of the tight junction. Cold Spring Harbor Perspectives in Biology 2009 1 2 a002584 2-s2.0-77950627398 10.1101/cshperspect.a002584
14. Rubin L. L., Staddon J. M., The cell biology of the blood-brain barrier. Annual Review of Neuroscience 1999 22 11 28 2-s2.0-0032936851 10.1146/annurev.neuro.22.1.11
15. Daneman R., Zhou L., Agalliu D., Cahoy J. D., Kaushal A., Barres B. A., The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS ONE 2010 5 10 2-s2.0-78149456928 10.1371/journal.pone.0013741 e13741
16. Predescu S. A., Predescu D. N., Malik A. B., Molecular determinants of endothelial transcytosis and their role in endothelial permeability. The American Journal of Physiology-Lung Cellular and Molecular Physiology 2007 293 4 L823 L842 2-s2.0-35348872064 10.1152/ajplung.00436.2006
17. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F. C., Schedl A., Hailer H., Kurzchalia T. V., Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001 293 5539 2449 2452 2-s2.0-0035964954 10.1126/science.1062688
18. Lisanti M. P., Tang Z., Sargiacomo M., Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: Implications for the biogenesis of caveolae. Journal of Cell Biology 1993 123 3 595 604 2-s2.0-0027363575 10.1083/jcb.123.3.595
19. Kaur C., Ling E. A., Blood brain barrier in hypoxic-ischemic conditions. Current Neurovascular Research 2008 5 1 71 81 2-s2.0-39749120467 10.2174/156720208783565645
20. Nag S., Manias J. L., Stewart D. J., Expression of endothelial phosphorylated caveolin-1 is increased in brain injury. Neuropathology and Applied Neurobiology 2009 35 4 417 426 2-s2.0-67649951530 10.1111/j.1365-2990. 2008.01009.x
21. Nicolazzo J. A., Katneni K., Drug transport across the blood-brain barrier and the impact of breast cancer resistance protein (ABCG2). Current Topics in Medicinal Chemistry 2009 9 2 130 147 2-s2.0-63349094264 10.2174/156802609787521580
22. Ransohoff R. M., Engelhardt B., The anatomical and cellular basis of immune surveillance in the central nervous system. Nature Reviews Immunology 2012 12 9 623 635 10.1038/nri3265
23. Uboldi C., Döring A., Alt C., Estess P., Siegelman M., Engelhardt B., L-Selectin-deficient SJL and C57BL/6 mice are not resistant to experimental autoimmune encephalomyelitis. European Journal of Immunology 2008 38 8 2156 2167 2-s2.0-51149089741 10.1002/eji.200838209
24. Engelhardt B., Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. Journal of the Neurological Sciences 2008 274 1-2 23 26 2-s2.0-53049110581 10.1016/j.jns.2008.05.019
25. Wilson E. H., Weninger W., Hunter C. A., Trafficking of immune cells in the central nervous system. Journal of Clinical Investigation 2010 120 5 1368 1379 2-s2.0-77951837763 10.1172/JCI41911
26. Engelhardt B., Ransohoff R. M., The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends in Immunology 2005 26 9 485 495 2-s2.0-23744475685 10.1016/j.it.2005.07.004
27. Carman C. V., Mechanisms for transcellular diapedesis: probing and pathfinding by 'invadosome-like protrusions'. Journal of Cell Science 2009 122 part 17 3025 3035 2-s2.0-70350351213 10.1242/jcs.047522
28. Ley K., Laudanna C., Cybulsky M. I., Nourshargh S., Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nature Reviews Immunology 2007 7 9 678 689 2-s2.0-34548230927 10.1038/nri2156
29. von Wedel-Parlow M., Schrot S., Lemmen J., Treeratanapiboon L., Wegener J., Galla H., Neutrophils cross the BBB primarily on transcellular pathways: an in vitro study. Brain Research 2011 1367 62 76 2-s2.0-78650509848 10.1016/j.brainres.2010.09.076
30. Simard A. R., Rivest S., Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB Journal 2004 18 9 998 1000 2-s2.0-6944234040 10.1096/fj.04-1517fje
31. Yilmaz G., Vital S., Yilmaz C. E., Stokes K. Y., Alexander J. S., Granger D. N., Selectin-mediated recruitment of bone marrow stromal cells in the postischemic cerebral microvasculature. Stroke 2011 42 3 806 811 2-s2.0-79952068809 10.1161/STROKEAHA.110.597088
32. Kim S., Chang K. A., Kim J., Park H. G., Ra J. C., Kim H. S., Suh Y. H., The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer's disease mice. PLoS ONE 2012 7 9 e45757 10.1371/journal.pone.0045757
33. Jeon D., Chu K., Lee S., Jung K., Kang K., Ban J., Kim S., Seo J. S., Won C., Kim M., Lee S. K., Roh J., A cell-free extract from human adipose stem cells protects mice against epilepsy. Epilepsia 2011 52 9 1617 1626 2-s2.0-80052519703 10.1111/j.1528-1167.2011.03182.x
34. Pendleton C., Li Q., Chesler D. A., Yuan K., Guerrero-Cazares H., Quinones-Hinojosa A., Mesenchymal stem cells derived from adipose tissue versus bone marrow: in vitro comparison of their tropism towards gliomas. PLoS ONE 2013 8 3 e58198 10.1371/journal.pone.0058198
35. Nakamizo A., Marini F., Amano T., Khan A., Studeny M., Gumin J., Chen J., Hentschel S., Vecil G., Dembinski J., Andreef M., Lang F. F., Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Research 2005 65 8 3307 3318 2-s2.0-33745228408 10.1158/0008-5472.CAN-04-1874
36. Roger M., Clavreul A., Venier-Julienne M., Passirani C., Sindji L., Schiller P., Montero-Menei C., Menei P., Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials 2010 31 32 8393 8401 2-s2.0-77956182174 10.1016/j.biomaterials.2010.07.048
37. Lee R. H., Pulin A. A., Seo M. J., Kota D. J., Ylostalo J., Larson B. L., Semprun-Prieto L., Delafontaine P., Prockop D. J., Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009 5 1 54 63 2-s2.0-67649171661 10.1016/j.stem.2009.05.003
38. Meirelles L. D. S., Caplan A. I., Nardi N. B., In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008 26 9 2287 2299 2-s2.0-55049092713 10.1634/stemcells.2007-1122
39. Rüster B., Göttig S., Ludwig R. J., Bistrian R., Müller S., Seifried E., Gille J., Henschler R., Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006 108 12 3938 3944 2-s2.0-33845277598 10.1182/blood-2006-05-025098
40. Sackstein R., Merzaban J. S., Cain D. W., Dagia N. M., Spencer J. A., Lin C. P., Wohlgemuth R., Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nature Medicine 2008 14 2 181 187 2-s2.0-38949183635 10.1038/nm1703
41. Chamberlain G., Smith H., Rainger G. E., Middleton J., Mesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shear. PLoS ONE 2011 6 9 2-s2.0-80053269532 10.1371/journal.pone.0025663 e25663
42. Brooke G., Tong H., Levesque J., Atkinson K., Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cells and Development 2008 17 5 929 940 2-s2.0-57449096881 10.1089/scd.2007.0156
43. Ip J. E., Wu Y., Huang J., Zhang L., Pratt R. E., Dzau V. J., Mesenchymal stem cells use integrin β 1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Molecular Biology of the Cell 2007 18 8 2873 2882 2-s2.0-34547740001 10.1091/mbc.E07-02-0166
44. Segers V. F. M., van Riet I., Andries L. J., Lemmens K., Demolder M. J., de Becker A. J. M. L., Kockx M. M., de Keulenaer G. W., Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. American Journal of Physiology-Heart and Circulatory Physiology 2006 290 4 H1370 H1377 2-s2.0-33646112920 10.1152/ajpheart.00523.2005
45. Steingen C., Brenig F., Baumgartner L., Schmidt J., Schmidt A., Bloch W., Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. Journal of Molecular and Cellular Cardiology 2008 44 6 1072 1084 2-s2.0-44649178243 10.1016/j.yjmcc.2008.03.010
46. Heiskanen A., Hirvonen T., Salo H., Impola U., Olonen A., Laitinen A., Tiitinen S., Natunen S., Aitio O., Miller-Podraza H., Wuhrer M., Deelder A. M., Natunen J., Laine J., Lehenkari P., Saarinen J., Satomaa T., Valmu L., Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconjugate Journal 2009 26 3 367 384 2-s2.0-62449124523 10.1007/s10719-008-9217-6
47. Matsushita T., Kibayashi T., Katayama T., Yamashita Y., Suzuki S., Kawamata J., Honmou O., Minami M., Shimohama S., Mesenchymal stem cells transmigrate across brain microvascular endothelial cell monolayers through transiently formed inter-endothelial gaps. Neuroscience Letters 2011 502 1 41 45 2-s2.0-80051791998 10.1016/j.neulet.2011.07.021
48. Teo G. S., Ankrum J. A., Martinelli R., Boetto S. E., Simms K., Sciuto T. E., Dvorak A. M., Karp J. M., Carman C. V., Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor- α -activated endothelial cells via both leukocyte-like and novel mechanisms. Stem Cells 2012 30 11 2472 2486 10.1002/stem.1198
49. Lin M. N., Shang D. S., Sun W., Li B., Xu X., Fang W. G., Zhao W. D., Cao L., Chen Y. H., Involvement of PI3K and ROCK signaling pathways in migration of bone marrow-derived mesenchymal stem cells through human brain microvascular endothelial cell monolayers. Brain Research 2013 1513 1 8 10.1016/j.brainres. 2013.03.035
50. Chamberlain G., Wright K., Rot A., Ashton B., Middleton J., Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS ONE 2008 3 8 2-s2.0-51849086413 10.1371/journal.pone.0002934 e2934
51. Sordi V., Malosio M. L., Marchesi F., Mercalli A., Melzi R., Giordano T., Belmonte N., Ferrari G., Leone B. E., Bertuzzi F., Zerbini G., Allavena P., Bonifacio E., Piemonti L., Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005 106 2 419 427 2-s2.0-22144491551 10.1182/blood-2004-09-3507
52. Honczarenko M., Le Y., Swierkowski M., Ghiran I., Glodek A. M., Silberstein L. E., Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006 24 4 1030 1041 2-s2.0-33745489036 10.1634/stemcells.2005-0319
53. Ponte A. L., Marais E., Gallay N., Langonné A., Delorme B., Hérault O., Charbord P., Domenech J., The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007 25 7 1737 1745 2-s2.0-34547217039 10.1634/stemcells.2007-0054
54. Feng J., He J. B. P., Dheen S. T., Tay S. S. W., Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004 22 3 415 427 2-s2.0-2942555661 10.1634/stemcells.22-3-415
55. de Becker A., van Hummelen P., Bakkus M., Broek I. V., de Wever J., de Waele M., van Riet I., Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 2007 92 4 440 449 2-s2.0-34547650992 10.3324/haematol.10475
56. Menge T., Zhao Y., Zhao J., Wataha K., Gerber M., Zhang J., Letourneau P., Redell J., Shen L., Wang J., Peng Z., Xue H., Kozar R., Cox C. S. Jr., Khakoo A. Y., Holcomb J. B., Dash P. K., Pati S., Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury. Science Translational Medicine 2012 4 161 161ra150 10.1126/scitranslmed.3004660
57. Gao Z., Zhang L., Hu J., Sun Y., Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles. Nanomedicine 2013 9 2 174 184 10.1016/j.nano.2012.06.003
58. Klopp A. H., Gupta A., Spaeth E., Andreeff M., Marini F. III, Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells 2011 29 1 11 19 2-s2.0-79951841819 10.1002/stem.559
59. Agalliu D., Schieren I., Heterogeneity in the developmental potential of motor neuron progenitors revealed by clonal analysis of single cells in vitro. Neural Development 2009 4 1, article 2 2-s2.0-62849085041 10.1186/1749-8104-4-2
60. Sarkar D., Spencer J. A., Phillips J. A., Zhao W., Schafer S., Spelke D. P., Mortensen L. J., Ruiz J. P., Vemula P. K., Sridharan R., Kumar S., Karnik R., Lin C. P., Karp J. M., Engineered cell homing. Blood 2011 118 25 e184 e191 2-s2.0-84055223060 10.1182/blood-2010-10-311464
61. Schaller B. J., Cornelius J. F., Sandu N., Buchfelder M., Molecular imaging of brain tumors personal experience and review of the literature. Current Molecular Medicine 2008 8 8 711 726 2-s2.0-59249093687 10.2174/156652408786733766
62. Sandu N., Spiriev T., Schaller B., Stem cell transplantation in neuroscience: the role of molecular imaging. Stem Cell Reviews 2012 8 4 1265 1266 10.1007/s12015-012-9389-0
63. Shyu W. C., Chen C. P., Lin S. Z., Lee Y. J., Li H., Efficient tracking of non-iron-labeled mesenchymal stem cells with serial MRI in chronic stroke rats. Stroke 2007 38 2 367 374 2-s2.0-33846571405 10.1161/01.STR.0000254463. 24655.14
64. Detante O., Valable S., de Fraipont F., Grillon E., Barbier E. L., Moisan A., Arnaud J., Moriscot C., Segebarth C., Hommel M., Remy C., Richard M. J., Magnetic resonance imaging and fluorescence labeling of clinical-grade mesenchymal stem cells without impacting their phenotype: study in a rat model of stroke. Stem Cells Translational Medicine 2012 1 4 333 340 10.5966/sctm.2011-0043
65. Lu S. S., Liu S., Zu Q. Q., Xu X. Q., Yu J., Wang J. W., Zhang Y., Shi H. B., In vivo MR imaging of intraarterially delivered magnetically labeled mesenchymal stem cells in a canine stroke model. PLoS ONE 2013 8 2 e54963 10.1371/journal.pone.0054963